RMD
Price
$239.59
Change
+$1.25 (+0.52%)
Updated
Oct 17 closing price
6 days until earnings call
RSMDF
Price
$17.70
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
7 days until earnings call
Ad is loading...

RMD vs RSMDF

Header iconRMD vs RSMDF Comparison
Open Charts RMD vs RSMDFBanner chart's image
ResMed
Price$239.59
Change+$1.25 (+0.52%)
Volume$839.33K
CapitalizationN/A
Resmed
Price$17.70
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
RMD vs RSMDF Comparison Chart
Loading...
RMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
RMD vs. RSMDF commentary
Oct 18, 2024

To understand the difference between Resmed Inc. (RMD) vs. Resmed Inc. - Chess Depository Interest (RSMDF) it is enough to know the definitions of Chess Depository Interest

Chess Depository Interest - Chess Depositary Interest (CDI) is the instrument developed by a subsidiary of the Australian Securities Exchange (ASX) that gives investors the same beneficial interests in foreign companies and funds as holding these shares and funds directly on their foreign exchange. CDIs investors receive W8-BEN and leverage the Australia-US tax treaty to reduce withholding tax on foreign income.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (RMD: $239.59 vs. RSMDF: $17.12)
Brand notoriety: RMD and RSMDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RMD: 87% vs. RSMDF: 100%
Market capitalization -- RMD: $29.13B vs. RSMDF: $32.67B
RMD [@Medical Specialties] is valued at $29.13B. RSMDF’s [@Medical Specialties] market capitalization is $32.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 2 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • RMD’s FA Score: 2 green, 3 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than RSMDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 5 TA indicator(s) are bullish.

  • RMD’s TA Score: 5 bullish, 5 bearish.

Price Growth

RMD (@Medical Specialties) experienced а +0.70% price change this week, while RSMDF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

RMD is expected to report earnings on Jan 23, 2025.

RSMDF is expected to report earnings on Jan 23, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($32.7B) has a higher market cap than RMD($29.1B). RSMDF has higher P/E ratio than RMD: RSMDF (37.59) vs RMD (31.34). RMD YTD gains are higher at: 40.277 vs. RSMDF (9.299). RMD has higher annual earnings (EBITDA): 1.43B vs. RSMDF (1.31B). RSMDF has more cash in the bank: 228M vs. RMD (210M). RMD has less debt than RSMDF: RMD (1.39B) vs RSMDF (1.72B). RMD has higher revenues than RSMDF: RMD (4.5B) vs RSMDF (4.02B).
RMDRSMDFRMD / RSMDF
Capitalization29.1B32.7B89%
EBITDA1.43B1.31B109%
Gain YTD40.2779.299433%
P/E Ratio31.3437.5983%
Revenue4.5B4.02B112%
Total Cash210M228M92%
Total Debt1.39B1.72B81%
FUNDAMENTALS RATINGS
RMD vs RSMDF: Fundamental Ratings
RMD
RSMDF
OUTLOOK RATING
1..100
7242
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
4578
SMR RATING
1..100
4242
PRICE GROWTH RATING
1..100
4254
P/E GROWTH RATING
1..100
2887
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (15) in the null industry is in the same range as RMD (18) in the Medical Specialties industry. This means that RSMDF’s stock grew similarly to RMD’s over the last 12 months.

RMD's Profit vs Risk Rating (45) in the Medical Specialties industry is somewhat better than the same rating for RSMDF (78) in the null industry. This means that RMD’s stock grew somewhat faster than RSMDF’s over the last 12 months.

RMD's SMR Rating (42) in the Medical Specialties industry is in the same range as RSMDF (42) in the null industry. This means that RMD’s stock grew similarly to RSMDF’s over the last 12 months.

RMD's Price Growth Rating (42) in the Medical Specialties industry is in the same range as RSMDF (54) in the null industry. This means that RMD’s stock grew similarly to RSMDF’s over the last 12 months.

RMD's P/E Growth Rating (28) in the Medical Specialties industry is somewhat better than the same rating for RSMDF (87) in the null industry. This means that RMD’s stock grew somewhat faster than RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RMD
RSI
ODDS (%)
Bearish Trend 1 day ago
57%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
48%
View a ticker or compare two or three
Ad is loading...
RMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
31%
Poorly correlated
+6.37%
RMD - RSMDF
20%
Poorly correlated
-0.35%
PFGTF - RSMDF
19%
Poorly correlated
N/A
SAFLF - RSMDF
9%
Poorly correlated
N/A
POSC - RSMDF
8%
Poorly correlated
+6.25%
More